自动化质谱系统用于单克隆免疫球蛋白测量与分型的性能评估
评估EXENT分析仪(EXENT检测)自动化MALDI-ToF质谱免疫分析检测单克隆免疫球蛋白的性能,在3个实验室的718例单克隆丙种球蛋白病患者、417例疾病对照和364例健康样本中与电泳方法比较。结果显示EXENT检测的检出率高于血清蛋白电泳(92.6% vs 85.1%),浓度相关性好(r=0.874),阳性样本同种型一致率97%。
要点
- EXENT质谱免疫分析可报告M蛋白的存在、浓度、同种型和质荷比。
- EXENT检测在单克隆丙种球蛋白病患者中检出率92.6%,高于血清蛋白电泳的85.1%。
- EXENT检测与血清蛋白电泳和免疫固定电泳在M蛋白检测和单克隆丙种球蛋白病评估上具有可比性。
核心结论
- EXENT检测与血清蛋白电泳和免疫固定电泳在M蛋白检测和单克隆丙种球蛋白病评估方面具有可比性。
研究设计与样本
- 在3个实验室中,使用电泳方法或EXENT检测对718例各种单克隆丙种球蛋白病患者、417例疾病对照和364例健康样本中的M蛋白进行评估。
- 按照CLSI指南建立EXENT检测的精密度、线性、测量区间下限(LLMI)和干扰性能。
主要发现
- EXENT检测在正常多克隆水平样本中IgG、IgA和IgM的测量下限分别为0.308 g/L、0.073 g/L和0.054 g/L。
- 所有同种型的总不精密度范围为3.7%至12.8%,实验室间不精密度为5.1%至14.3%。
- 治疗性单克隆抗体被标记为内源性IgG kappa M蛋白,当满足m/z阈值时未显示干扰。
- EXENT检测在92.6%的单克隆丙种球蛋白病患者中检测到M蛋白,而血清蛋白电泳(SPE)为85.1%。
- EXENT检测与电泳方法的浓度相关性强(r=0.874),阳性样本的同种型一致率为97%。
关键数值与推荐
- 临床临界值设定为IgG 0.359 g/L、IgA 0.325 g/L、IgM 0.197 g/L。
临床怎么用
- EXENT检测可用于单克隆免疫球蛋白的测量和分型,作为电泳技术的自动化替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Monoclonal proteins are detected using electrophoretic techniques and used to help diagnose plasma cell dyscrasias. The Immunoglobulin Isotypes (GAM) for the EXENT® analyser (EXENT assay) is an automated MALDI-ToF mass spectrometry immunoassay, designed for use with Optilite® turbidimetric assays for the identification and measurement of monoclonal immunoglobulins (M-proteins). The assay reports M-protein presence, concentration, isotype, and mass/charge ratio (m/z). METHODS: The EXENT assay precision performance, linearity, lower limit of the measuring interval (LLMI) and interference were established per CLSI guidelines. M-proteins were evaluated using electrophoretic methods or the EXENT assay in clinical samples from 718 patients with various monoclonal gammopathies, 417 disease controls and 364 healthy samples at 3 different laboratories. RESULTS: The EXENT assay demonstrated a lower measuring limit of 0.308 g/L, 0.073 g/L and 0.054 g/L for IgG, IgA, and IgM in samples with normal polyclonal levels. Total imprecision ranged from 3.7 to 12.8% across all isotypes, and between-laboratory was 5.1-14.3%. Therapeutic monoclonal antibodies were flagged from endogenous IgG kappa M-proteins and showed no interference when m/z thresholds were met. Clinical cut-offs were established at 0.359 g/L (IgG), 0.325 g/L (IgA), and 0.197 g/L (IgM). The EXENT assay detected M-proteins in 92.6% of monoclonal gammopathy patients versus 85.1% by serum protein electrophoresis (SPE), with strong concentration correlations (r = 0.874) and 97% isotype concordance in positive samples. CONCLUSIONS: The EXENT assay demonstrated comparability to SPE and immunofixation electrophoresis (IFE) for M-protein detection and the evaluation of monoclonal gammopathies.
引用
- Ashby J, McEntee D, Sakrikar D, et al. Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins. Clin Chim Acta. 2026. PMID: 41765198. doi:10.1016/j.cca.2026.120930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。